Nationwide Fund Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,964
| Closed | -$936K | – | 88 |
|
|
2017
Q3 | $936K | Sell |
7,964
-3,233
| -29% | -$380K | ﹤0.01% | 1836 |
|
|
2017
Q2 | $893K | Sell |
11,197
-386
| -3% | -$30.8K | ﹤0.01% | 1847 |
|
|
2017
Q1 | $594K | Buy |
11,583
+2,707
| +30% | +$139K | ﹤0.01% | 2063 |
|
|
2016
Q4 | $332K | Sell |
8,876
-36,663
| -81% | -$1.37M | ﹤0.01% | 2384 |
|
|
2016
Q3 | $3.09M | Sell |
45,539
-500
| -1% | -$33.9K | 0.01% | 1194 |
|
|
2016
Q2 | $2.56M | Sell |
46,039
-7,436
| -14% | -$413K | 0.01% | 1250 |
|
|
2016
Q1 | $3.36M | Sell |
53,475
-3,033
| -5% | -$190K | 0.01% | 1121 |
|
|
2015
Q4 | $5.32M | Buy |
56,508
+8,742
| +18% | +$823K | 0.02% | 885 |
|
|
2015
Q3 | $3.84M | Sell |
47,766
-3,088
| -6% | -$248K | 0.02% | 1053 |
|
|
2015
Q2 | $6.1M | Sell |
50,854
-14,370
| -22% | -$1.72M | 0.03% | 864 |
|
|
2015
Q1 | $6.81M | Sell |
65,224
-6,031
| -8% | -$630K | 0.03% | 820 |
|
|
2014
Q4 | $6.91M | Sell |
71,255
-12,610
| -15% | -$1.22M | 0.03% | 763 |
|
|
2014
Q3 | $6.55M | Sell |
83,865
-1,860
| -2% | -$145K | 0.03% | 795 |
|
|
2014
Q2 | $5.42M | Sell |
85,725
-44,275
| -34% | -$2.8M | 0.02% | 935 |
|
|
2014
Q1 | $8.73M | Sell |
130,000
-3,450
| -3% | -$232K | 0.04% | 570 |
|
|
2013
Q4 | $8.59M | Buy |
133,450
+3,913
| +3% | +$252K | 0.04% | 651 |
|
|
2013
Q3 | $8.29M | Sell |
129,537
-3,663
| -3% | -$234K | 0.04% | 623 |
|
|
2013
Q2 | $4.13M | Buy |
+133,200
| New | +$4.13M | 0.02% | 903 |
|